Optiver Holding B.V. Bio N Tech Se Transaction History

Optiver Holding B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$88.96 - $112.35 $622 - $786	-7 Reduced 33.33%	14 $1,000
Q4 2023 Feb 13, 2024	SELL	$90.91 - $112.75 $1,000 - $1,240	-11 Reduced 34.38%	21 $2,000
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $3,152 - $4,002	32 New	32 $3,000
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $14.6 Million - $20.4 Million	170,616 New	170,616 $18.6 Million

363

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.